AzTrials
AzTrials

Eating DisordersVISANNCT06711783

Treatment of Adolescent Anorexia Nervosa

A study testing Family based therapy in people with Eating Disorders, run by Region Örebro County at 1 site in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

VISAN is a naturalistic study of family based treatment of Anorexia nervosa in adolescnet girls. Read more about this study

Who is it for?
Ages 11 to 17 years
Conditions the study is for
Eating Disorders
What is being tested?
Family based therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSweden
Study dates
1 Aug 2024to 31 Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Having been diagnosed with f500 or f501 and being planned for family based therapy at the unit.

Who cannot join

  • being subjected to care by the social welfare system

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sanna Gustafsson A Gustafsson, Ass prof contact

+46722495986

sanna.aila-gustafsson@regionorebrolan.se

Sweden1 site, 1 recruiting
  • Orebro eating disorder unit

    Örebro, S-70185

    Sanna A Gustafsson, Ass Prof, +46722495986, sanna.aila-gustafsson@regionorebrolan.se

    Recruiting

Other trials in Sweden

About this study

Official title: VISAN - vårdkedja i Samverkan för Unga Patienter Med Anorexia Nervosa (Collaborative Chain of Care in Adolescnt Anorexia Nervosa Treatment)

VISAN is a naturalistic study of family based treatment of Anorexia nervosa in adolescnet girls.

Being tested
Family based therapy
Keywords
anorexia nervosa
Medical subject headings
Feeding and Eating Disorders, Anorexia Nervosa

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Family based therapyBehavioural

    Family based therapy following the Maudsley model

Study groups in NCT06711783
Study groupRoleWhat they receive
Family based treatmentExperimentalFamily based treatment including the whole chain of care, such as day care and in patiant care when necessary. The interventions includes consultation with dietician, psyciotherapist, LEAP-Y and Skills training based on an individual plan.
Receives: Behavioral: Family based therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Remission

    No longer fulfilling criteria for an eating disorder

    Measured: End of treatment (assessed up to 1 year)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2024
  2. Study start1 Aug 2024
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06711783
Sponsor's protocol ID
281931
Acronym
VISAN
Status last verified
Apr 2026
First submitted
25 Nov 2024
Last updated
1 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Family based therapy in people with Eating Disorders, run by Region Örebro County at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sanna Gustafsson A Gustafsson, Ass prof (+46722495986, sanna.aila-gustafsson@regionorebrolan.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Remission (time frame: End of treatment (assessed up to 1 year)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in